UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Supply and Clinical Application of Actinium-225 and Bismuth-213

Seminars in nuclear medicine, 2020-03, Vol.50 (2), p.119-123

2020

Link zum Volltext

Verfügbarkeit prüfen

Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA

European urology, 2021-03, Vol.79 (3), p.343-350

2021

Link zum Volltext

Verfügbarkeit prüfen

Global experience with PSMA-based alpha therapy in prostate cancer

European journal of nuclear medicine and molecular imaging, 2021-12, Vol.49 (1), p.30-46

2021

Link zum Volltext

Verfügbarkeit prüfen

Diverse metabolic response of cancer cells treated with a 213Bi-anti-EGFR-immunoconjugate

Scientific reports, 2021-03, Vol.11 (1), p.6227-6227, Article 6227

2021

Link zum Volltext

Verfügbarkeit prüfen

Dose escalation study of targeted alpha therapy with [225Ac]Ac-DOTA-substance P in recurrence glioblastoma – safety and efficacy

European journal of nuclear medicine and molecular imaging, 2021-10, Vol.48 (11), p.3595-3605

2021

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Global experience with PSMA‑based alpha therapy in prostate cancer

European journal of nuclear medicine and molecular imaging, 2021-12, Vol.49 (1), p.73-73

2021

Link zum Volltext

Verfügbarkeit prüfen

DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy

PloS one, 2014-02, Vol.9 (2), p.e88239

2014

Link zum Volltext

Verfügbarkeit prüfen

Development of Targeted Alpha Therapy from Bench to Bedside

Journal of medical imaging and radiation sciences, 2019-12, Vol.50 (4), p.S18-S20

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?

International journal of molecular sciences, 2023-11, Vol.24 (21), p.15701

2023

Link zum Volltext

Verfügbarkeit prüfen

Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes

Current radiopharmaceuticals, 2012-07, Vol.5 (3), p.221

2012

Link zum Volltext

Verfügbarkeit prüfen

Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity

European journal of nuclear medicine and molecular imaging, 2021-12, Vol.49 (1), p.54-63

2021

Link zum Volltext

Verfügbarkeit prüfen

In vitro studies of 223Ra- and 225Ac-labelled α-zirconium phosphate as potential carrier for alpha targeted therapy

Journal of radioanalytical and nuclear chemistry, 2023-05, Vol.332 (5), p.1527-1532

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative Analysis of Morphological and Functional Effects of 225Ac- and 177Lu-PSMA Radioligand Therapies (RLTs) on Salivary Glands

International journal of molecular sciences, 2023-12, Vol.24 (23), p.16845

2023

Link zum Volltext

Verfügbarkeit prüfen

Separation of 221Fr from 225Ac using diglycolamide solid extractants

Journal of radioanalytical and nuclear chemistry, 2023-05, Vol.332 (5), p.1483-1488

2023

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Targeted α- and β - -Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

Cancers, 2020-04, Vol.12 (4), p.1017

2020

Link zum Volltext

Verfügbarkeit prüfen

First patient exceeding 5-year complete remission after 225Ac-PSMA-TAT

European journal of nuclear medicine and molecular imaging, 2021, Vol.48 (1), p.311-312

2021

Link zum Volltext

Verfügbarkeit prüfen

α-Zirconium(IV) Phosphate: Static Study of 225Ac Sorption in an Acidic Environment and Its Kinetic Sorption Study Using natEu as a Model System for 225Ac

Materials, 2023-08, Vol.16 (17), p.5732

2023

Link zum Volltext

Verfügbarkeit prüfen

Preparation and characterization of α-zirconium phosphate as a perspective material for separation of 225Ac and 213Bi

Journal of radioanalytical and nuclear chemistry, 2023-05, Vol.332 (5), p.1475-1481

2023

Link zum Volltext

Verfügbarkeit prüfen

Resonant laser ionization and mass separation of 225Ac

Scientific reports, 2023-01, Vol.13 (1), p.1347-1347, Article 1347

2023

Link zum Volltext

Verfügbarkeit prüfen

Antitumor Immunity Induced after α Irradiation

Neoplasia (New York, N.Y.), 2014-04, Vol.16 (4), p.319-328

2014

Link zum Volltext

Verfügbarkeit prüfen

Assessment of 213Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-13C]pyruvate and [18F]FDG

Scientific reports, 2019-06, Vol.9 (1), p.8294-8294, Article 8294

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeted alpha therapy for glioblastoma

Frontiers in medicine, 2022-12, Vol.9, p.1085245-1085245

2022

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy

The Journal of nuclear medicine (1978), 2020-01, Vol.61 (1), p.62

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model

EJNMMI research, 2017-07, Vol.7 (1), p.57-16, Article 57

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer

Prostate cancer and prostatic diseases, 2022-03, Vol.25 (1), p.71-78

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 288

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(275)
Mit Volltextzugriff
(276)

Publikationsform

Artikel
(287)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Supply and Clinical Application of Actinium-225 and Bismuth-213

Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA

Global experience with PSMA-based alpha therapy in prostate cancer

Diverse metabolic response of cancer cells treated with a 213Bi-anti-EGFR-immunoconjugate

Dose escalation study of targeted alpha therapy with [225Ac]Ac-DOTA-substance P in recurrence glioblastoma – safety and efficacy

Correction to: Global experience with PSMA‑based alpha therapy in prostate cancer

DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy

Development of Targeted Alpha Therapy from Bench to Bedside

Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?

Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes

Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity

In vitro studies of 223Ra- and 225Ac-labelled α-zirconium phosphate as potential carrier for alpha targeted therapy

Comparative Analysis of Morphological and Functional Effects of 225Ac- and 177Lu-PSMA Radioligand Therapies (RLTs) on Salivary Glands

Separation of 221Fr from 225Ac using diglycolamide solid extractants

Preclinical Targeted α- and β - -Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

First patient exceeding 5-year complete remission after 225Ac-PSMA-TAT

α-Zirconium(IV) Phosphate: Static Study of 225Ac Sorption in an Acidic Environment and Its Kinetic Sorption Study Using natEu as a Model System for 225Ac

Preparation and characterization of α-zirconium phosphate as a perspective material for separation of 225Ac and 213Bi

Resonant laser ionization and mass separation of 225Ac

Antitumor Immunity Induced after α Irradiation

Assessment of 213Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-13C]pyruvate and [18F]FDG

Targeted alpha therapy for glioblastoma

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy

Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model

Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer

Suchergebnisse filtern